| Dr Hugh Harrison Loeffler, MD | |
|
1138 Lexington Rd Ste 290, Georgetown, KY 40324-9672 | |
| (502) 863-0721 | |
| (502) 863-6104 |
| Full Name | Dr Hugh Harrison Loeffler |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 16 Years |
| Location | 1138 Lexington Rd Ste 290, Georgetown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255584223 | NPI | - | NPPES |
| 7100126050 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 44636 (Kentucky) | Primary |
| 207P00000X | Emergency Medicine | 44636 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bourbon Community Hospital | Paris, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20090715000150 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Entity Name | Kentucky Mso Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164867883 PECOS PAC ID: 0749450633 Enrollment ID: O20110901000380 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Entity Name | Hospital Medicine Services Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528433802 PECOS PAC ID: 9234432881 Enrollment ID: O20160803001623 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hugh Harrison Loeffler, MD Po Box 910670, Lexington, KY 40591-0670 Ph: (859) 971-4685 | Dr Hugh Harrison Loeffler, MD 1138 Lexington Rd Ste 290, Georgetown, KY 40324-9672 Ph: (502) 863-0721 |
News Archive
Health spending has declined, according to a new study, and it appears to be affecting insurance company bottom lines.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
› Verified 3 days ago
Dr. Kent Edward Taylor, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1140 Lexington Rd, Suite 202, Georgetown, KY 40324 Phone: 502-868-1100 Fax: 502-868-5612 | |
Dr. Matthew C Birdwhistell, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Rd, Suite 290, Georgetown, KY 40324 Phone: 502-863-0721 Fax: 502-863-6104 | |
Robert Craig Martin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Rd, Suite 290, Georgetown, KY 40324 Phone: 502-863-0721 Fax: 502-863-6104 | |
Kristen R Stakelin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Rd, Ste 290, Georgetown, KY 40324 Phone: 502-863-0721 Fax: 502-863-6104 | |
Naba Saeed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 | |
Benjamin P Lyon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1138 Lexington Rd, Ste 290, Georgetown, KY 40324 Phone: 502-863-0721 Fax: 502-863-6104 |